Effectiveness and safety of hemostatic powder for patients who treated with prostate biopsy

Effectiveness and safety of hemostatic powder including carboxymethyl starch for patients who treated with prostate biopsy

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0008584

Enrollment

Registered

2023-06-29

Start date

2022-10-13

Completion date

Unknown

Last updated

2023-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : The subjects will be divided into two groups by RCT.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: patients who treated with prostate biopsy to R/O prostate neoplasms

Exclusion criteria

Exclusion criteria: less than 19, older than 80

Design outcomes

Primary

Measure	Time frame
The change of hemoglobin	—

Secondary

Measure	Time frame
microscopic hematuria;complications	—

Countries

Korea, Republic of

Contacts

Public ContactSe Young Choi

Chung-Ang University

alse3025@hanmail.net+82-2-6299-1810

Outcome results